{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:39:46Z","timestamp":1790872786401,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2024 Hebei Province Medical Science Research Project Plan","award":["NO.20241062"],"award-info":[{"award-number":["NO.20241062"]}]},{"name":"President's Fund of Hebei University","award":["NO.School 20220036"],"award-info":[{"award-number":["NO.School 20220036"]}]},{"name":"Hospital Foundation of the Affiliated Hospital of Hebei University","award":["NO.2022QC32"],"award-info":[{"award-number":["NO.2022QC32"]}]},{"name":"Baoding Science and Technology Plan","award":["NO.2241ZF297"],"award-info":[{"award-number":["NO.2241ZF297"]}]},{"name":"The Natural Scientific Foundation of Hebei Province","award":["(NO. H2021206177"],"award-info":[{"award-number":["(NO. H2021206177"]}]},{"DOI":"10.13039\/501100008238","name":"Hebei Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["NO. 22377759D"],"award-info":[{"award-number":["NO. 22377759D"]}],"id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11010-025-05322-y","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:16:49Z","timestamp":1749626209000},"page":"5411-5427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["FOXM1 upregulation, promotes immune escape in gastric cancer through activation of Notch signaling pathway"],"prefix":"10.1007","volume":"480","author":[{"given":"Shangkun","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangkui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianliang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"5322_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"5322_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R (2020) Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21114012","journal-title":"Int J Mol Sci"},{"key":"5322_CR3","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J (2023) Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 29:2452\u20132468. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2452","journal-title":"World J Gastroenterol"},{"key":"5322_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, Feng Z, Zhang G, Yao M (2024) Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon 10:e37046. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37046","journal-title":"Heliyon"},{"key":"5322_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad Gastroenterologiczny 14:26\u201338. https:\/\/doi.org\/10.5114\/pg.2018.80001","journal-title":"Przeglad Gastroenterologiczny"},{"key":"5322_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB (2023) Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol 20:338\u2013349. https:\/\/doi.org\/10.1038\/s41571-023-00747-0","journal-title":"Nat Rev Clin Oncol"},{"key":"5322_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","volume":"21","author":"FM Johnston","year":"2019","unstructured":"Johnston FM, Beckman M (2019) Updates on management of gastric cancer. Curr Oncol Rep 21:67. https:\/\/doi.org\/10.1007\/s11912-019-0820-4","journal-title":"Curr Oncol Rep"},{"key":"5322_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH (2023) Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 16:57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3","journal-title":"J Hematol Oncol"},{"key":"5322_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I (2022) Epidemiology of stomach cancer. World J Gastroenterol 28:1187\u20131203. https:\/\/doi.org\/10.3748\/wjg.v28.i12.1187","journal-title":"World J Gastroenterol"},{"key":"5322_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA (2024) Cancer treatments: past, present, and future. Cancer Genet 286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002","journal-title":"Cancer Genet"},{"key":"5322_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1158\/0008-5472.Can-21-3371","volume":"82","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, Hollander PD, Mani SA (2022) Forkhead box transcription factors: double-edged swords in cancer. Cancer Res 82:2057\u20132065. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-3371","journal-title":"Cancer Res"},{"key":"5322_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-023-03090-7","volume":"23","author":"P Tabnak","year":"2023","unstructured":"Tabnak P, HasanzadeBashkandi A, Ebrahimnezhad M, Soleimani M (2023) Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics. Cancer Cell Int 23:238. https:\/\/doi.org\/10.1186\/s12935-023-03090-7","journal-title":"Cancer Cell Int"},{"key":"5322_CR13","doi-asserted-by":"publisher","first-page":"G284","DOI":"10.1152\/ajpgi.00032.2024","volume":"327","author":"PC Li","year":"2024","unstructured":"Li PC, Dai SY, Lin YS, Chang YT, Liu CC, Wang IC, Lee MF (2024) Forkhead box M1 mediates metabolic reprogramming in human colorectal cancer cells. Am J Physiol Gastrointest Liver Physiol 327:G284\u2013G294. https:\/\/doi.org\/10.1152\/ajpgi.00032.2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5322_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/hep.31196","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y, Lu L, Tu J, Zhang J, Xiong T, Fan W, Wang J, Li M, Chen Y, Steggerda J, Peng H, Chen Y, Li TWH, Zhou ZG, Mato JM, Seki E, Liu T, Yang H, Lu SC (2020) Reciprocal regulation between forkhead box M1\/NF-\u03baB and methionine adenosyltransferase 1A drives liver cancer. Hepatology 72:1682\u20131700. https:\/\/doi.org\/10.1002\/hep.31196","journal-title":"Hepatology"},{"key":"5322_CR15","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1080\/21655979.2021.1989969","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang B, Diao H, Wang P, Guan F, Liu H (2021) microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1. Bioengineered 12:9094\u20139102. https:\/\/doi.org\/10.1080\/21655979.2021.1989969","journal-title":"Bioengineered"},{"key":"5322_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166698","author":"S Zhang","year":"2023","unstructured":"Zhang S, Wang J, Hu W, He L, Tang Q, Li J, Jie M, Li X, Liu C, Ouyang Q, Yang S, Hu C (2023) RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.166698","journal-title":"JCI Insight"},{"key":"5322_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100863","volume":"36","author":"Q Tang","year":"2023","unstructured":"Tang Q, Liu C, Zhang S, He L, Liu Y, Wang J, Zhao X, Li X (2023) FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer. Neoplasia 36:100863. https:\/\/doi.org\/10.1016\/j.neo.2022.100863","journal-title":"Neoplasia"},{"key":"5322_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-023-02872-1","volume":"42","author":"R Xu","year":"2023","unstructured":"Xu R, Lee YJ, Kim CH, Min GH, Kim YB, Park JW, Kim DH, Kim JH, Yim H (2023) Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1. J Exp Clin Cancer Res 42:302. https:\/\/doi.org\/10.1186\/s13046-023-02872-1","journal-title":"J Exp Clin Cancer Res"},{"key":"5322_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.727","volume":"10","author":"K Ma","year":"2022","unstructured":"Ma K, Sun Z, Li X, Guo J, Wang Q, Teng M (2022) Forkhead box M1 recruits FoxP3(+) Treg cells to induce immune escape in hilar cholangiocarcinoma. Immun Inflammat Dis 10:e727. https:\/\/doi.org\/10.1002\/iid3.727","journal-title":"Immun Inflammat Dis"},{"key":"5322_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17:807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6","journal-title":"Cell Mol Immunol"},{"key":"5322_CR21","doi-asserted-by":"publisher","first-page":"1255611","DOI":"10.3389\/fimmu.2023.1255611","volume":"14","author":"F Yasinjan","year":"2023","unstructured":"Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H (2023) Immunotherapy: a promising approach for glioma treatment. Front Immunol 14:1255611. https:\/\/doi.org\/10.3389\/fimmu.2023.1255611","journal-title":"Front Immunol"},{"key":"5322_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036863","author":"JH Cha","year":"2020","unstructured":"Cha JH, Chan LC, Song MS, Hung MC (2020) New approaches on cancer immunotherapy. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a036863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5322_CR23","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.1038\/s41598-024-70184-1","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Dong A, Rasteh AM, Wang P, Weng J (2024) Identification of the novel exhausted T cell CD8 + markers in breast cancer. Sci Rep 14:19142. https:\/\/doi.org\/10.1038\/s41598-024-70184-1","journal-title":"Sci Rep"},{"key":"5322_CR24","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA (2021) Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184:5309\u20135337. https:\/\/doi.org\/10.1016\/j.cell.2021.09.020","journal-title":"Cell"},{"key":"5322_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi A, Ribas A (2020) Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol 20:25\u201339. https:\/\/doi.org\/10.1038\/s41577-019-0218-4","journal-title":"Nat Rev Immunol"},{"key":"5322_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/ott.S235714","volume":"13","author":"S Wang","year":"2020","unstructured":"Wang S, Hu C, Xie F, Liu Y (2020) Use of programmed death receptor-1 and\/or programmed death ligand 1 inhibitors for the treatment of brain metastasis of lung cancer. Onco Targets Ther 13:667\u2013683. https:\/\/doi.org\/10.2147\/ott.S235714","journal-title":"Onco Targets Ther"},{"key":"5322_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/prd.12548","volume":"96","author":"S Groeger","year":"2000","unstructured":"Groeger S, Meyle J (2024) The role of programmed death receptor (PD-)1\/PD-ligand (L)1 in periodontitis and cancer. Periodontol 2000 96:150\u2013169. https:\/\/doi.org\/10.1111\/prd.12548","journal-title":"Periodontol"},{"key":"5322_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105383","author":"IA Vathiotis","year":"2021","unstructured":"Vathiotis IA, Gomatou G, Stravopodis DJ, Syrigos N (2021) Programmed death-ligand 1 as a regulator of tumor progression and metastasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105383","journal-title":"Int J Mol Sci"},{"key":"5322_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126447","author":"M Zanelli","year":"2024","unstructured":"Zanelli M, Fragliasso V, Parente P, Bisagni A, Sanguedolce F, Zizzo M, Broggi G, Ricci S, Palicelli A, Foroni M, Gozzi F, Gentile P, Morini A, Koufopoulos N, Caltabiano R, Cimino L, Fabozzi M, Cavazza A, Neri A, Ascani S (2024) Programmed death ligand 1 (PD-L1) expression in lymphomas: state of the art. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25126447","journal-title":"Int J Mol Sci"},{"key":"5322_CR30","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L (2020) PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res 10:727\u2013742","journal-title":"Am J Cancer Res"},{"key":"5322_CR31","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/s41388-019-0700-2","volume":"38","author":"L Castagnoli","year":"2019","unstructured":"Castagnoli L, Cancila V, Cordoba-Romero SL, Faraci S, Talarico G, Belmonte B, Iorio MV, Milani M, Volpari T, Chiodoni C, Hidalgo-Miranda A, Tagliabue E, Tripodo C, Sangaletti S, Di Nicola M, Pupa SM (2019) WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer. Oncogene 38:4047\u20134060. https:\/\/doi.org\/10.1038\/s41388-019-0700-2","journal-title":"Oncogene"},{"key":"5322_CR32","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1038\/s41467-021-24164-y","volume":"12","author":"N Roper","year":"2021","unstructured":"Roper N, Velez MJ, Chiappori A, Kim YS, Wei JS, Sindiri S, Takahashi N, Mulford D, Kumar S, Ylaya K, Trindade C, Manukyan I, Brown AL, Trepel JB, Lee JM, Hewitt S, Khan J, Thomas A (2021) Notch signaling and efficacy of PD-1\/PD-L1 blockade in relapsed small cell lung cancer. Nat Commun 12:3880. https:\/\/doi.org\/10.1038\/s41467-021-24164-y","journal-title":"Nat Commun"},{"key":"5322_CR33","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/jci129317","volume":"129","author":"YP Xu","year":"2019","unstructured":"Xu YP, Lv L, Liu Y, Smith MD, Li WC, Tan XM, Cheng M, Li Z, Bovino M, Aub\u00e9 J, Xiong Y (2019) Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Invest 129:4316\u20134331. https:\/\/doi.org\/10.1172\/jci129317","journal-title":"J Clin Invest"},{"key":"5322_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13046-022-02536-6","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Gigante I, Serino G, Pizzuto E, Dituri F, Valentini MF, Wang J, Chen X, Armentano R, Calvisi DF, Giannelli G (2022) Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-\u03b2 inhibition. J Exp Clin Cancer Res 41:331. https:\/\/doi.org\/10.1186\/s13046-022-02536-6","journal-title":"J Exp Clin Cancer Res"},{"key":"5322_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, Grossi V, Simone C, Armentano R, Evert M, Calvisi DF, Giannelli G (2022) CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer Res 41:65. https:\/\/doi.org\/10.1186\/s13046-022-02283-8","journal-title":"J Exp Clin Cancer Res"},{"key":"5322_CR36","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1080\/15548627.2020.1752497","volume":"17","author":"YQ Di","year":"2021","unstructured":"Di YQ, Han XL, Kang XL, Wang D, Chen CH, Wang JX, Zhao XF (2021) Autophagy triggers CTSD (cathepsin D) maturation and localization inside cells to promote apoptosis. Autophagy 17:1170\u20131192. https:\/\/doi.org\/10.1080\/15548627.2020.1752497","journal-title":"Autophagy"},{"key":"5322_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-023-02711-3","volume":"42","author":"Y Cui","year":"2023","unstructured":"Cui Y, Li J, Zhang P, Yin D, Wang Z, Dai J, Wang W, Zhang E, Guo R (2023) B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. J Exp Clin Cancer Res 42:146. https:\/\/doi.org\/10.1186\/s13046-023-02711-3","journal-title":"J Exp Clin Cancer Res"},{"key":"5322_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-024-03175-9","volume":"43","author":"H Wang","year":"2024","unstructured":"Wang H, Yao L, Chen J, Li Y, Su Z, Liu Y, Li W, Xiong Y, Gao H, Zhang X, Zhou Y (2024) The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma. J Exp Clin Cancer Res 43:252. https:\/\/doi.org\/10.1186\/s13046-024-03175-9","journal-title":"J Exp Clin Cancer Res"},{"key":"5322_CR39","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.2147\/jir.S453245","volume":"17","author":"X Qin","year":"2024","unstructured":"Qin X, Li H, Wu J, Tang W, Li W, Li K (2024) PGM5-AS1 promotes progression of diffuse large B-Cell lymphoma and immune escape by regulating miR-503-5p. J Inflamm Res 17:4187\u20134197. https:\/\/doi.org\/10.2147\/jir.S453245","journal-title":"J Inflamm Res"},{"key":"5322_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J (2022) A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene 822:146325. https:\/\/doi.org\/10.1016\/j.gene.2022.146325","journal-title":"Gene"},{"key":"5322_CR41","first-page":"2140","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T (2023) A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am J Trans Res 15:2140\u20132155","journal-title":"Am J Trans Res"},{"key":"5322_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7424","volume":"13","author":"L Ding","year":"2024","unstructured":"Ding L, Sun M, Sun Y, Li J, Zhang Z, Dang S, Zhang J, Yang B, Dai Y, Zhou Q, Zhou D, Li E, Peng S, Li G (2024) MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis. Cancer Med 13:e7424. https:\/\/doi.org\/10.1002\/cam4.7424","journal-title":"Cancer Med"},{"key":"5322_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","volume":"149","author":"C R\u00f6cken","year":"2023","unstructured":"R\u00f6cken C (2023) Predictive biomarkers in gastric cancer. J Cancer Res Clin Oncol 149:467\u2013481. https:\/\/doi.org\/10.1007\/s00432-022-04408-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"5322_CR44","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton RE, Al Hallak MN, Diab M, Azmi AS (2020) Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 39:1179\u20131203. https:\/\/doi.org\/10.1007\/s10555-020-09925-3","journal-title":"Cancer Metastasis Rev"},{"key":"5322_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","volume":"92","author":"MA Khan","year":"2023","unstructured":"Khan MA, Khan P, Ahmad A, Fatima M, Nasser MW (2023) FOXM1: a small fox that makes more tracks for cancer progression and metastasis. Semin Cancer Biol 92:1\u201315. https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.007","journal-title":"Semin Cancer Biol"},{"key":"5322_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijsu.2017.09.076","volume":"48","author":"D Jiang","year":"2017","unstructured":"Jiang D, Jiang L, Liu B, Huang H, Li W, Zhang T, Zu G, Zhang X (2017) Clinicopathological and prognostic significance of FoxM1 in gastric cancer: a meta-analysis. Int J Surg 48:38\u201344. https:\/\/doi.org\/10.1016\/j.ijsu.2017.09.076","journal-title":"Int J Surg"},{"key":"5322_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/2159-8290.Cd-22-0475","volume":"13","author":"SS Onkar","year":"2023","unstructured":"Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, Oesterreich S (2023) The great immune escape: understanding the divergent immune response in breast cancer subtypes. Cancer Discov 13:23\u201340. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-0475","journal-title":"Cancer Discov"},{"key":"5322_CR48","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1007\/s00432-023-04737-8","volume":"149","author":"A Kallingal","year":"2023","unstructured":"Kallingal A, Olszewski M, Maciejewska N, Brankiewicz W, Baginski M (2023) Cancer immune escape: the role of antigen presentation machinery. J Cancer Res Clin Oncol 149:8131\u20138141. https:\/\/doi.org\/10.1007\/s00432-023-04737-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"5322_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB (2020) Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett 470:126\u2013133. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.009","journal-title":"Cancer Lett"},{"key":"5322_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092361","author":"C Galassi","year":"2021","unstructured":"Galassi C, Musella M, Manduca N, Maccafeo E, Sistigu A (2021) The immune privilege of cancer stem cells: a key to understanding tumor immune escape and therapy failure. Cells. https:\/\/doi.org\/10.3390\/cells10092361","journal-title":"Cells"},{"key":"5322_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/bs9.0000000000000149","volume":"5","author":"YJ Zhou","year":"2023","unstructured":"Zhou YJ, Li G, Wang J, Liu M, Wang Z, Song Y, Zhang X, Wang X (2023) PD-L1: expression regulation. Blood Sci (Baltimore, Md) 5:77\u201391. https:\/\/doi.org\/10.1097\/bs9.0000000000000149","journal-title":"Blood Sci (Baltimore, Md)"},{"key":"5322_CR52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yu D, Qian H, Shi Y, Tao Z (2024) CD8(+) T cell-based cancer immunotherapy. J Transl Med 22:394. https:\/\/doi.org\/10.1186\/s12967-024-05134-6","journal-title":"J Transl Med"},{"key":"5322_CR53","doi-asserted-by":"publisher","first-page":"1281763","DOI":"10.3389\/fncel.2023.1281763","volume":"17","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Duan Z, Cui Y (2023) CD8(+) T cells in brain injury and neurodegeneration. Front Cell Neurosci 17:1281763. https:\/\/doi.org\/10.3389\/fncel.2023.1281763","journal-title":"Front Cell Neurosci"},{"key":"5322_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccell.2023.12.010","volume":"42","author":"ME Hoekstra","year":"2024","unstructured":"Hoekstra ME, Slagter M, Urbanus J, Toebes M, Slingerland N, de Rink I, Kluin RJC, Nieuwland M, Kerkhoven R, Wessels LFA, Schumacher TN (2024) Distinct spatiotemporal dynamics of CD8(+) T cell-derived cytokines in the tumor microenvironment. Cancer Cell 42:157\u201367.e9. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.010","journal-title":"Cancer Cell"},{"key":"5322_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166982","volume":"1870","author":"W Xue","year":"2024","unstructured":"Xue W, Wu K, Guo X, Chen C, Huang T, Li L, Liu B, Chang H, Zhao J (2024) The pan-cancer landscape of glutamate and glutamine metabolism: a comprehensive bioinformatic analysis across 32 solid cancer types. Biochim Biophys Acta 1870:166982. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166982","journal-title":"Biochim Biophys Acta"},{"key":"5322_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, Kaur B, Han H, Yu J (2023) The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol 16:45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z","journal-title":"J Hematol Oncol"},{"key":"5322_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, Gangadaran P, Ahn BC (2023) Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (London, England) 43:525\u2013561. https:\/\/doi.org\/10.1002\/cac2.12416","journal-title":"Cancer Commun (London, England)"},{"key":"5322_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/ijmm.2019.4418","volume":"45","author":"M Katoh","year":"2020","unstructured":"Katoh M, Katoh M (2020) Precision medicine for human cancers with Notch signaling dysregulation (Review). Int J Mol Med 45:279\u2013297. https:\/\/doi.org\/10.3892\/ijmm.2019.4418","journal-title":"Int J Mol Med"},{"key":"5322_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, Chu Q (2022) Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther 7:95. https:\/\/doi.org\/10.1038\/s41392-022-00934-y","journal-title":"Signal Transduct Target Ther"},{"key":"5322_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/icb.2012.53","volume":"91","author":"M Mathieu","year":"2013","unstructured":"Mathieu M, Cotta-Grand N, Daudelin JF, Th\u00e9bault P, Labrecque N (2013) Notch signaling regulates PD-1 expression during CD8(+) T-cell activation. Immunol Cell Biol 91:82\u201388. https:\/\/doi.org\/10.1038\/icb.2012.53","journal-title":"Immunol Cell Biol"},{"key":"5322_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6985","volume":"13","author":"K Ogi","year":"2024","unstructured":"Ogi K, Iwamoto T, Sasaya T, Nishiyama K, Tokura T, Sasaki T, Dehari H, Arihara Y, Murase K, Saito M, Someya M, Takada K, Miyazaki A (2024) Notch signaling genes and CD8(+) T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: a retrospective study. Cancer Med 13:e6985. https:\/\/doi.org\/10.1002\/cam4.6985","journal-title":"Cancer Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05322-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05322-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05322-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:48:01Z","timestamp":1760168881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05322-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5322"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05322-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they do not have any financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee at Affiliated Hospital of Hebei University granted approval for the study (No. SCXK-2019\u20130009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The manuscript has neither been previously published nor is under consideration by any other journal. The authors have all approved the content of the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Every participant provided informed consent for the collection of samples.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}